A basic training course for those working on drug safety in the EU. This course has been designed to provide basic training and a good introduction to those concerned with veterinary pharmacovigilance.
5-6 Nov 2019
& 5-6 May 2020 , 14-15 Oct 2020
GBP 1,399 1,199 *
EUR 1,959 1,679 *
USD 2,182 1,870 *
* When you book before 20 Sep
This course has been designed to provide basic training and a good introduction to those concerned with veterinary pharmacogivilance. New entrants and support staff as well as experienced personnel who require a better understanding of veterinary drug safety will benefit from the practical guidance provided. Key terminology will be explained and roles and responsibilities will be clarified. There will be plenty of time for interaction and questions and answers to enable participants to get a good understanding of this complex subject.
Benefits of attending:
This course will be beneficial to those new to veterinary pharmacovigilance, support staff and experienced personnel who require a better understanding of drug safety in their current role. Adverse event monitoring and drug safety officers together with regulatory affairs and personnel from registration departments will also find this seminar useful.
What is pharmacovigilance?
The current regulatory framework and its global impact
Adverse event reporting
Causality assessment
Pharmacovigilance case studies
Electronic communication in pharmacovigilance
Minimising the impact of data with errors
Clinical trial AE reporting requirements
Literature searches
Periodic safety update reports (PSURs)
Practical workshop on PSURs
Declan O'Rourke
Declan O’Rourke has over 20 years’ experience in industry where he has held technical, marketing, product development, clinical development, production and pharmacovigilance roles.
Declan is a veterinary surgeon, holds a Diploma in Marketing, a Master of Business Administration and a Fellowship of the Royal College of Veterinary Surgeons. He now directs Ortec Consultancy specialising in EU pharmacovigilance and represented IFAH-EU in the VICH Working Group on pharmacovigilance.
Declan is also an Honarary Associate Professor in Veterinary Pharmaceutical Development at Nottingham Veterinary School, Past President of British Cattle Veterinary Association and a member of the Veterinary Products Committee (VPC).
| 5-6 Nov 2019 | ||||
| 5-6 Nov 2019 | DoubleTree by Hilton London-West End, London | GBP 1,399.00 EUR 1,959.00 USD 2,182.00 + VAT @ 20.00% |
GBP 1,199.00 EUR 1,679.00 USD 1,870.00 Until 20 Sep* |
Enrol now |
| 5-6 May 2020 | ||||
| 5-6 May 2020 | Rembrandt Hotel, London | GBP 1,399.00 EUR 1,959.00 USD 2,182.00 + VAT @ 20.00% |
Enrol now | |
| 14-15 Oct 2020 | ||||
| 14-15 Oct 2020 | Rembrandt Hotel, London | GBP 1,399.00 EUR 1,959.00 USD 2,182.00 + VAT @ 20.00% |
Enrol now | |
* Note the early booking discount cannot be combined with any other offers or promotional code
“[The speaker was] enthusiastic, clear and easy to understand. The material was relevant and well explained.”
Donal Donnelly, Clinical Veterinary Surgeon and Deputy QPPV, Norbrook Laboratories Ltd
“In general very interesting course. ”
Guy Werquin, Veterinary Doctor, Versele-Laga
“Good general overview about pharmacovigilance. Talented and passionate speaker. Many practical examples. ”
Tom Decock, Regulatory Affairs, Versele-Laga
“A good course to get a general introduction to Veterinary Pharmacovigilance, for those new to pharmacovigilance. The speaker, Declan O'Rourke, is very experienced and very enthusiastic in his presentation. ”
Anders Hessellund Bisgaard, QA & RA Assistant, Salfarm Danmark A/S
“Very good course. Personally I would have needed more time on PSURs and signal detection and less on cases assessment. Very informative and enthusiastic. ”
Claire Milard, Pharmacovigilance manager, Merial - Boehringer Ingelheim
“Well updated, easy to understand for a person with non-english mother tongue.”
Lars Speilberg, Manager R&D, Scanvacc AS
“Enjoyed method of presenting.”
Lisa Glen, Project Manager, Benchmark Animal Health
“interesting, experienced speaker, great overview of pharmacovigilance.”
Karen Roels, Clinical Trial Manager, Huvepharma NV
“Structured, logical and critical approach to a complex case handling. ”
Maud Christelle Ricatti, DVM, ACD Pharmaceuticals
“Very good”
Luciano Gobbi, Associate Director Regulatory Affairs, MSD Animal Health SRL
“Overall I was very impressed with the course”
Lee Smith, Pharmacovigilance E9O, Veterinary Medicines Directorate
“Very good”
Felicity Caddick, veterinary technical advisor, Animlacare
“Interesting and informative course. Enthusiastic and informative speaker. ”
Hannah Robbins, Pharmacovigilance VRO, Veterinary Medicines Directorate
“Very interesting program, well organized, with a very experienced speaker, with good presentation technique and with a good ability to capture the interest of the participants. the presentations were clear and interesting.”
Marlene Delgado, QPPV, ZOOPAN S.A.
“Relevant, good course”
Katrine Underlien, Drug Safety Coordinator, Pharmacosmos
“I think that this course is great for people looking for more insight into pharmacovigilance and would recommend it”
Jamie Jardine, Administrative Officer, Veterinary Medicines Directorate
“Good knowledge sharing, open dialogue, not all slides in the binder up to date, overall very positive ”
Angela van der Salm, Director Pharmacovigilance, DADA Consultancy